Active Not Recruiting EARLY_PHASE1 INTERVENTIONAL 3-arm
NCT07423663
Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions
Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions :A Randomized Controlled Clinical Trial
Sponsor: Suez Canal University
Conditions
Asymptomatic Apical Periodontitis
Interventions
Calcium Hydroxide Intracanal medication Calcium silicate based intracanal medication Pectin
Updated 1 time since 2026 Last updated: Feb 13, 2026 Started: Sep 1, 2024 Primary completion: Mar 10, 2026 Completion: Apr 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A EARLY_PHASE1 clinical study on Asymptomatic Apical Periodontitis, this trial is ongoing. The trial is conducted by Suez Canal University and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Active Not Recruiting — EARLY_PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Suez Canal University
- University of Leeds
Data source: Suez Canal University
For direct contact, visit the study record on ClinicalTrials.gov .